Article Link: FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea D...
FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression
Article Link: FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression March 19, 2019 — The U.S. Food and Dru...
FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer
Article Link: FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell ...
Allergan Announces FDA Approval of Avycaz (ceftazidime and avibactam) for Pediatric Patients
Article Link: Allergan Announces FDA Approval of Avycaz (ceftazidime and avibactam) for Pediatric Patients DUBLIN, March 18, 2019 /PRNews...
FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension
Article Link: FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the Reduction of Intraocular Pressure in Open-Angle Glaucoma...
FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Atopic Dermatitis in Adolescents
Article Link: FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Atopic Dermatitis in Adolescents CAMBRIDGE, Mass. and TARRYTOWN, N...
FDA Approves Trazimera (trastuzumab-qyyp), a Biosimilar to Herceptin
Article Link: FDA Approves Trazimera (trastuzumab-qyyp), a Biosimilar to Herceptin March 11, 2019 – Pfizer Inc. today announced the...
FDA Grants Genentech’s Tecentriq in Combination With Abraxane Accelerated Approval for People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer
Article Link: FDA Grants Genentech’s Tecentriq in Combination With Abraxane Accelerated Approval for People With PD-L1-Positive, Metastatic Triple-Neg...
FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression
Article Link: FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression March 5, 2019 — The U.S. Food and D...
FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD
Article Link: FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD STAMFORD, Conn...
